Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Stan Smith is Director at Maia Biotechnology. OQRO lists 23 transactions filed with the SEC under this name, the latest on Nov 17, 2026, each linked to the official Form 4.
Director
Disclosures on record
23
Companies involved
1
Stan Smith bought shares on the open market in 2022, 2023, 2024, 2025 and 2026.
Stan Smith reported 52 open-market purchases and 0 sales since 2022; purchases in 5 different years, most recently 2026.
| Year | Bought | Sold |
|---|---|---|
| 2026 | $200K3×3 trades | — |
| 2025 | $389K11×11 trades | — |
| 2024 | $797K4×4 trades | — |
| 2023 | $456K25×25 trades | — |
| 2022 | $1.03M9×9 trades | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
11 buys, median −10.1 pts vs S&P 500, beat it 4 of 11 times.
Average +3.4 pts vs S&P 500. Each buy is one disclosure of open-market purchases in one company on one filing date, filed Nov 4, 2024 to Jun 2, 2026, measured from the first close after the filing. Past results, not a forecast.
11 purchases disclosed; 27% of the 11 measured at 90 days finished ahead of the index. $1,000 placed after each of the 6 purchases disclosed since 2025-11-16 would be worth $4.3K today ($6K put in); the same in the S&P 500 (SPY): $6.5K.
Rank 56 of the 82 insiders with at least 10 purchases measured at 90 days. The middle of that group is −5.5 pts (median, against the S&P 500).
Equal weight counts every purchase once; by size counts it for its disclosed dollars. Both are measured from the first close after it was reported. Past results describe the past, not a forecast. How this is measured · Leaderboard
Maia BiotechnologyMAIA
23 disclosures · Nov 2024 – Nov 2026 · 17 bought
Nov 13, 2026Bought~$81Kdisclosed Nov 17
DetailsOfficial recordNov 16, 2026Bought~$19Kdisclosed Nov 17
DetailsOfficial recordSep 30, 202639Kdisclosed Oct 3
DetailsOfficial recordJun 30, 202632Kdisclosed Jul 3
DetailsOfficial recordJun 1, 2026Bought~$100Kdisclosed Jun 2
DetailsOfficial recordMar 31, 202633Kdisclosed Apr 3
DetailsOfficial recordSep 19, 2022Bought~$10Kdisclosed Jan 12
DetailsOfficial recordMay 1, 202420Kdisclosed Jan 12
DetailsOfficial recordDec 31, 202529Kdisclosed Jan 5
DetailsOfficial recordDec 22, 2025Bought~$70Kdisclosed Dec 23
DetailsOfficial recordDec 22, 202557Kdisclosed Dec 23
DetailsOfficial recordDec 5, 2025Bought~$5.5Kdisclosed Dec 10
DetailsOfficial recordDec 5, 2025Bought~$5.5Kdisclosed Dec 10
DetailsOfficial recordDec 5, 2025Bought~$5.5Kdisclosed Dec 10
DetailsOfficial recordNov 26, 2025Bought~$16Kdisclosed Dec 1
DetailsOfficial recordNov 24, 2025Bought~$9.9Kdisclosed Nov 27
DetailsOfficial recordNov 25, 2025Bought~$15Kdisclosed Nov 27
DetailsOfficial recordJun 3, 2025Bought~$50Kdisclosed Jun 5
DetailsOfficial recordMay 8, 2025Bought~$100Kdisclosed May 12
DetailsOfficial recordFeb 24, 2025Bought~$75Kdisclosed Mar 5
DetailsOfficial recordMar 3, 2025Bought~$38Kdisclosed Mar 5
DetailsOfficial recordDec 13, 2024Bought~$47K
DetailsOfficial recordNov 1, 2024Bought~$251Kdisclosed Nov 4
DetailsOfficial recordAs of the latest filing on , Stan Smith reported holding 1,619,178 shares of Maia Biotechnology (MAIA), worth about $1.64M at the last close of $1 (Nov 16, 2026), held through a see footnote. In the last 12 months, Stan Smith bought $337K in 11 open-market purchases.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Maia Biotechnology MAIA | 1,619,178 | 1.62M see footnote | $1 | $1.64M | Nov 16, 2026 |
Is this Stan Smith’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Stan Smith reported 52 open-market purchases and 0 sales here, 2022 to 2026.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
On the latest SEC Form 4, dated Nov 16, 2026, Stan Smith reported holding 1,619,178 shares of Maia Biotechnology (MAIA), held indirectly. At the last close of $1 on Nov 16, 2026, that is about $1.64M. This is the stake disclosed in filings, not a net worth.
In SEC filings of the last 12 months, Stan Smith reported 11 open-market purchases worth $337K, and no open-market sale. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
Stan Smith bought shares on the open market in 2022, 2023, 2024, 2025 and 2026.
In SEC filings since 2022: the latest open-market purchase is from 2026; no open-market sale is on record.
Maia Biotechnology (MAIA), from 2022 to 2026: 52 purchases and 0 sales.